异种与同种脱细胞真皮基质在组织扩张器乳房再造中的随机对照研究
该前瞻性单盲随机对照试验纳入90例(最终分析68例)即刻组织扩张器乳房再造患者,比较人源与牛源脱细胞真皮基质的安全性和有效性。结果显示两组总体并发症率无显著差异(25% vs 27%,P=0.85),扩张器丢失率亦无显著差异(7% vs 17%,P=0.14)。
要点
- 人源与牛源ADM总体并发症率无显著差异(25% vs 27%,P=0.85)
- 扩张器丢失率牛源组较高但未达统计学显著(17% vs 7%,P=0.14)
- 材料选择需结合患者筛选、咨询和成本综合考虑
核心结论
- 即刻组织扩张器乳房再造中使用人源或牛源ADM,并发症率和植入物丢失率相似。
研究设计与样本
- 前瞻性、单盲、随机对照试验,2011年4月至2016年6月共随机90例,最终分析68例(人源ADM 36例/55侧乳房;牛源ADM 32例/48侧乳房)。
- 排除既往接受过患侧乳房放疗的患者。
主要发现
- 总体并发症率:人源ADM组25%(n=14),牛源ADM组27%(n=13),P=0.85。
- 主要并发症和需再次手术的并发症趋势相似。
- 扩张器丢失率:人源ADM组7%(n=4),牛源ADM组17%(n=8),P=0.14。
- 两组基线特征相似。
临床怎么用
- 人源与牛源ADM均可用于即刻组织扩张器乳房再造,选择时需综合患者筛选、咨询和成本因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the increased use of acellular dermal matrix (ADM) in breast reconstruction, the number of available materials has increased. There is a relative paucity of high-quality outcomes data for use of different ADMs. OBJECTIVES: The goal of this study was to compare the outcomes between a human (HADM) and a bovine ADM (BADM) in implant-based breast reconstruction. METHODS: A prospective, single-blinded, randomized controlled trial was conducted to evaluate differences in outcomes between HADM and BADM for patients undergoing immediate tissue expander breast reconstruction. Patients with prior radiation to the index breast were excluded. Patient and surgical characteristics were collected and analyzed. RESULTS: From April 2011 to June 2016, a total of 90 patients were randomized to a mesh group, with 68 patients (HADM, 36 patients/55 breasts; BADM, 32 patients/48 breasts) included in the final analysis. Baseline characteristics were similar between the 2 groups. No significant differences in overall complication rates were identified between HADM (n = 14, 25%) and BADM (n = 13, 27%) (P = 0.85). Similar trends were identified for major complications and complications requiring reoperation. Tissue expander loss was identified in 7% of HADM patients (n = 4) and 17% of BADM patients (n = 8) (P = 0.14). CONCLUSIONS: Similar complication and implant loss rates were found among patients undergoing immediate tissue expander breast reconstruction with HADM or BADM. Regardless of what material is used, careful patient selection and counseling, and cost consideration, help to improve outcomes and sustainability in immediate breast reconstruction.
引用
- Asaad M, Selber JC, Adelman DM, et al. Allograft vs Xenograft Bioprosthetic Mesh in Tissue Expander Breast Reconstruction: A Blinded Prospective Randomized Controlled Trial. Aesthet Surg J. 2021. PMID: 33693461. doi:10.1093/asj/sjab115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。